From: Transcriptomics of type 2 diabetic and healthy human neutrophils
 |  | Healthy (N = 8) | Type 2 Diabetic (N = 13) | Total Cohort (N = 21*) | p-value |
---|---|---|---|---|---|
Age (mean in years ± SD) |  | 39 (± 9.63) | 58 (± 11.05) | 51 (± 14.04) | 0.007 |
Sex (no., %) | Male | 4 (50%) | 7 (53.85%) | 11 (52.38%) | Â |
Female | 4 (50%) | 6 (46.15%) | 10 (47.62%) | – | |
Ethnicity | Caucasian | 5 (62.50%) | 4 (30.77%) | 9 (42.86%) | Â |
Hispanic | 0 | 1 (7.69%) | 1 (4.76%) | Â | |
African-American | 3 (37.50%) | 8 (61.54%) | 11 (52.38%) | – | |
Smoking Status (no., %) | Smokers | 1 (12.50%) | 1 (7.69%) | 2 (9.52%) | Â |
Former Smokers | 0 | 2 (15.38%) | 2 (9.52%) | Â | |
Never Smokers | 7 (87.50%) | 10 (76.92%) | 17 (80.95%) | – | |
BMI (kg/m2; mean ± SD) |  | 28.56 (± 4.47) | 30.46 (± 6.27) | 29.74 (± 5.61) | 0.47 |
Blood Cholesterol (mg/dl; mean ± SD) |  | 144.25 (± 20.61) | 183.77 (± 66.97) | 168.71 (± 56.80) | 0.12 |
Blood Glucose (mg/dl; mean ± SD) | Normal (<  100 mg/dl) | 96.50 (± 3.54) | – | 96.50 (± 3.54) |  |
Pre-diabetes (100-125 mg/dl) | 107 (± 3.81) | – | 107 (± 3.81) |  | |
Diabetes (> 126 mg/dl) | 209 | 267.77 (± 123.38) | 263.57 (± 119.58) | 0.003 | |
HbA1c % (mean ± SD) | Normal (<  5.7% HbA1c) | – | – | – |  |
Pre-diabetes (5.7–6.4% HbA1c) | – | 6.15 (± 0.17) | 6.15 (± 0.17) |  | |
Diabetes (>  6.5% HbA1c) | – | 9.64 (± 2.63) | 9.64 (± 2.63) | – | |
Periodontal Condition (no., %) | Healthy | 8 (100%) | 0 | 8 (38.09%) | Â |
Mild | 0 | 3 (23.08%) | 3 (14.29%) | Â | |
Moderate | 0 | 6 (46.15%) | 6 (28.57%) | Â | |
Severe | 0 | 2 (15.38%) | 2 (9.52%) | Â | |
Gingivitis | 0 | 2 (15.38%) | 2 (9.52%) | – | |
Neutrophil Count (mil. of cells, mean ± SD) |  | 104.88 (± 57.23) | 123.69 (± 65.68) | 116.52 (± 61.83) | 0.51 |
Monocyte Count (mil. of cells, mean ± SD) |  | 72.50 (± 34.13) | 99.59 (± 73.72) | 89.27 (± 62.05) | 0.34 |